Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Acadia Healthcare Company, Inc.ACHC · Entity 4312 | Director | May 06, 2026 | May 08, 2026 |
| CONDUENT IncCNDT · Entity 1191 | Director | February 19, 2026 | February 20, 2026 |
| FLOTEK INDUSTRIES INC/CN/FTK · Entity 5092 | Director | May 15, 2026 | May 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Acadia Healthcare Company, Inc.
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,152 |
Reported balance
After 2026-05-06 transaction · row 1
1 source rowRow 1 · 2026-05-06 · Grant · Acquired 6,331 · Balance 28,152 F1: Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.
CONDUENT Inc
Report date February 19, 2026 · Filed February 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 166,102 |
Reported balance
After 2026-02-19 transaction · row 1
1 source rowRow 1 · 2026-02-19 · Purchase · Acquired 60,000 · Balance 166,102 F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $ 1.415 to $1.470, inclusive. The reporting person undertakes to provide to Conduent Incorporated (the Company), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $ 1.415 to $1.470, inclusive. The reporting person undertakes to provide to Conduent Incorporated (the Company), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
FLOTEK INDUSTRIES INC/CN/
Report date May 15, 2026 · Filed May 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 88,243 |
Reported balance
After 2026-05-15 transaction · row 1
1 source rowRow 1 · 2026-05-15 · Grant · Acquired 5,099 · Balance 88,243 F1: Restricted Stock Awards ("RSAs") granted as consideration for service on the Board. RSAs vest on the earlier of the one-year anniversary of the grant date or the next annual shareholders meeting (provided such meeting occurs at least 50 weeks after the grant date). |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Awards ("RSAs") granted as consideration for service on the Board. RSAs vest on the earlier of the one-year anniversary of the grant date or the next annual shareholders meeting (provided such meeting occurs at least 50 weeks after the grant date).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2026 Filed May 18, 2026 17:28 UTC | FLOTEK INDUSTRIES INC/CN/ FTK · Entity 5092 | GrantCommon Shares | 5,099 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-26-000057 · wk-form4_1779139734.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,243 F1 · shares: Restricted Stock Awards ("RSAs") granted as consideration for service on the Board. RSAs vest on the earlier of the one-year anniversary of the grant date or the next annual shareholders meeting (provided such meeting occurs at least 50 weeks after the grant date). Read SEC document |
| May 06, 2026 Filed May 8, 2026 21:23 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 6,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-215070 · ownership.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,152 F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 16:30 UTC | CONDUENT Inc CNDT · Entity 1191 | PurchaseCommon Stock | 60,000 | $1.44 | $86,580.00 |
DisclosureSEC source: 0001830184-26-000004 · wk-form4_1771605042.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,102 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $ 1.415 to $1.470, inclusive. The reporting person undertakes to provide to Conduent Incorporated (the Company), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| January 15, 2026 Filed Jan 20, 2026 21:16 UTC | CONDUENT Inc CNDT · Entity 1191 | GrantCommon Stock | 92,683 | $2.05 | $190,000.15 |
DisclosureSEC source: 0001830184-26-000002 · wk-form4_1768943764.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,102 F1 · shares: Award of Deferred Stock Units that represent the right to receive one share of common stock upon separation of service as a director. Read SEC document |
| October 31, 2025 Filed Nov 3, 2025 21:07 UTC | CONDUENT Inc CNDT · Entity 1191 | GrantCommon Stock | 13,419 | $2.36 | $31,668.84 |
DisclosureSEC source: 0001677703-25-000145 · wk-form4_1762204058.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,419 F1 · shares: Award of Deferred Stock Units that represent the right to receive one share of common stock on the earlier of one year following date of grant or termination of service. Read SEC document |
| May 29, 2025 Filed May 30, 2025 21:10 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 7,032 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-079847 · ownership.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,821 F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning May 29, 2026. Read SEC document |
| May 16, 2025 Filed May 19, 2025 19:44 UTC | FLOTEK INDUSTRIES INC/CN/ FTK · Entity 5092 | GrantCommon Shares | 6,394 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-25-000056 · wk-form4_1747683845.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,144 F1 · shares: Restricted Stock Awards ("RSAs") granted as consideration for service on the Board. RSAs vest on the earlier of the one-year anniversary of the grant date or the next annual shareholders meeting (provided such meeting occurs at least 50 weeks after the grant date). Read SEC document |
| June 05, 2024 Filed Jun 5, 2024 21:12 UTC | FLOTEK INDUSTRIES INC/CN/ FTK · Entity 5092 | GrantCommon Shares | 22,173 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-24-000067 · wk-form4_1717621966.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,750 F1 · shares: Restricted Stock Awards ("RSAs") granted as consideration for service on the Board. RSAs vest on the earlier of the one-year anniversary of the grant date or the next annual shareholders meeting (provided such meeting occurs at least 50 weeks after the grant date). Read SEC document |
| May 23, 2024 Filed May 28, 2024 23:06 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 2,414 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-065511 · ownership.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,789 F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning May 23, 2025. Read SEC document |
| November 17, 2023 Filed Nov 17, 2023 20:27 UTC | FLOTEK INDUSTRIES INC/CN/ FTK · Entity 5092 | PurchaseCommon Shares | 7,593 | $3.90 | $29,612.70 |
DisclosureSEC source: 0000928054-23-000207 · wk-form4_1700252811.xml · nonDerivative · entry 2 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,576 Read SEC document |
| November 17, 2023 Filed Nov 17, 2023 20:27 UTC | FLOTEK INDUSTRIES INC/CN/ FTK · Entity 5092 | PurchaseCommon Shares | 100 | $3.89 | $389.00 |
DisclosureSEC source: 0000928054-23-000207 · wk-form4_1700252811.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,983 F1 · balance_after: The number of shares beneficially owned following the transaction have been adjusted to reflect the one for six reverse split of the common stock effective September 25, 2023. Read SEC document |
| July 01, 2023 Filed Jul 6, 2023 01:15 UTC | FLOTEK INDUSTRIES INC/CN/ FTK · Entity 5092 | GrantCommon Shares | 136,986 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-23-000120 · wf-form4_168860610692327.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,294 F1 · shares: Restricted stock grant awarded as part of Board compensation. Shares vest at the earlier of one year from date of grant and the annual shareholders meeting, but in no event less than one year from date of grant. Read SEC document |
| May 18, 2023 Filed May 19, 2023 21:05 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 2,229 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-013391 · doc4.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,375 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 18, 2024. Read SEC document |
| August 04, 2022 Filed Aug 8, 2022 22:13 UTC | FLOTEK INDUSTRIES INC/CN/ FTK · Entity 5092 | GrantCommon Shares | 82,645 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-22-000165 · wf-form4_165999678412620.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,308 F1 · shares: Grant of shares for annual retainer. Shares vest at the earlier of one year from date of grant and the 2023 annual meeting. Read SEC document |
| May 19, 2022 Filed May 20, 2022 21:13 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 2,303 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-019074 · doc4.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,146 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 19, 2023. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 22:48 UTC | FLOTEK INDUSTRIES INC/CN/ FTK · Entity 5092 | GrantCommon Shares | 47,170 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-21-000105 · wf-form4_162310611262606.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,663 F1 · shares: Grant of shares for annual retainer. Shares vest at the earlier of one year from date of grant and the 2022 annual meeting. Read SEC document |
| May 06, 2021 Filed May 7, 2021 21:05 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 2,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-018709 · doc4.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,843 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 6, 2022. Read SEC document |
| November 25, 2020 Filed Nov 25, 2020 21:16 UTC | FLOTEK INDUSTRIES INC/CN/ FTK · Entity 5092 | GrantCommon Shares | 14,493 | $0.00 | $0.00 |
DisclosureSEC source: 0000928054-20-000210 · wf-form4_160633898118833.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,493 F1 · shares: Award grant of 14,493 shares based on a closing price of $2.30 per share on November 24, 2020. Shares vest at the 2021 annual stockholder meeting. Read SEC document |
| October 28, 2020 Filed Oct 30, 2020 21:05 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 5,293 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-029941 · doc4.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,293 F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning October 28, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.